Literature DB >> 24718743

[Headache therapy - pain therapy: common features and differences].

S Förderreuther1, A Straube.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24718743     DOI： 10.1007/s00482-014-1418-2

Source DB:  PubMed          Journal:  Schmerz        ISSN： 0932-433X            Impact factor:   1.107


× No keyword cloud information.
  19 in total

1.  Acupuncture versus topiramate in chronic migraine prophylaxis: a randomized clinical trial.

Authors:  C-P Yang; M-H Chang; P-E Liu; T-C Li; C-L Hsieh; K-L Hwang; H-H Chang
Journal:  Cephalalgia       Date:  2011-10-21       Impact factor: 6.292

Review 2.  [Recommendations on classification of German pain treatment services].

Authors:  R Sabatowski; C Maier; A Willweber-Strumpf; M Thomm; P Nilges; H Kayser; R Casser
Journal:  Schmerz       Date:  2011-08       Impact factor: 1.107

3.  Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs.

Authors:  P Rossi; C Di Lorenzo; J Faroni; F Cesarino; G Nappi
Journal:  Cephalalgia       Date:  2006-09       Impact factor: 6.292

4.  Letter: Ergotamine-induced headaches.

Authors:  G Wainscott; G Volans; M Wilkinson
Journal:  Br Med J       Date:  1974-06-29

5.  OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.

Authors:  Stephen D Silberstein; Andrew M Blumenfeld; Roger K Cady; Ira M Turner; Richard B Lipton; Hans-Christoph Diener; Sheena K Aurora; Mai Sirimanne; Ronald E DeGryse; Catherine C Turkel; David W Dodick
Journal:  J Neurol Sci       Date:  2013-06-19       Impact factor: 3.181

6.  Probable medication-overuse headache: the effect of a 2-month drug-free period.

Authors:  Peter Zeeberg; Jes Olesen; Rigmor Jensen
Journal:  Neurology       Date:  2006-05-17       Impact factor: 9.910

7.  Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

Authors:  H-C Diener; G Bussone; J C Van Oene; M Lahaye; S Schwalen; P J Goadsby
Journal:  Cephalalgia       Date:  2007-04-18       Impact factor: 6.292

8.  Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study.

Authors:  Charly Gaul; Christina van Doorn; Nadine Webering; Martha Dlugaj; Zaza Katsarava; Hans-Christoph Diener; Günther Fritsche
Journal:  J Headache Pain       Date:  2011-05-05       Impact factor: 7.277

9.  Prevalence of primary headaches in Germany: results of the German Headache Consortium Study.

Authors:  M-S Yoon; Z Katsarava; M Obermann; G Fritsche; M Oezyurt; K Kaesewinkel; A Katsarova; I Santowski; H Diener; S Moebus
Journal:  J Headache Pain       Date:  2012-03-07       Impact factor: 7.277

10.  Period prevalence of self-reported headache in the general population in Germany from 1995-2005 and 2009: results from annual nationwide population-based cross-sectional surveys.

Authors:  Andreas Straube; Bernhard Aicher; Steffanie Förderreuther; Thomas Eggert; Janin Köppel; Stefan Möller; Roland Schneider; Gunther Haag
Journal:  J Headache Pain       Date:  2013-02-14       Impact factor: 7.277
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.